Genomic Medicine and Pharmacogenetics: What Clinicians Should Absolutely Know
-
Register
- User - $40
The emergence of genomics and precision medicine is sure to bring about seismic changes in healthcare delivery. This course will discuss the current state of genomic medicine and provide you with a basic genetic overview for use in critical analysis. Using case studies, this intriguing session will critically examine the expanding field of genomic medicine (including pharmacogenomics and use of biomarkers) and demonstrate how its integration into clinical practice may help to more precisely evaluate, diagnose, manage and prevent selected acute and chronic medical conditions. As well as addressing concerns about genomic medicine such as should you use them, how to order them, what to tell your patients and ethical concerns you may face.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.50 contact hours; 1.25 are pharmacology
Expiration Date: June 30, 2025
$40.00
LEARNING OBJECTIVES
As a result of this activity, you will be able to:
- Identify the benefits of genomics medicine in developing treatment strategies for patients in primary care.
- Utilize pharmacogenomic principles in prescribing appropriate medications for use for selected morbidities.
- Discuss ethics concerns related to the use of genomics in medical care.
Christine Kessler, MN, ANP, CNS, BC-ADM, CDTC, FAANP
Founder and Clinical Consultant
Metabolic Medicine Associates
Christine Kessler is an award-winning nurse practitioner, national/international speaker, prolific author, and clinical consultant specializing in General Endocrinology, Obesity, and Metabolic Medicine. During her 48 years of nursing (40 years in advanced practice) she has held diverse roles in management, research, academia (as assistant professor undergraduate and graduate nursing), and especially clinical practice; the latter as a critical care clinical specialist, an acute care nurse practitioner (as hospitalist & intensivist) and adult endocrinology nurse practitioner.
After 15 years as the senior nurse practitioner at a large hospital Department of Endocrinology and Metabolic Medicine, Christine now focuses on providing diabetes and general endocrine services, as well as weight-loss management, in rural Virginia. Christine has received numerous top medical clinical practice and patient satisfaction awards, including the Coin of Excellence personally awarded by the Surgeon General for having the highest patient satisfaction rating of all health care providers in the Army WORLDWIDE. Christine is a Fellow of the American Association of Nurse Practitioners.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your “My Courses/Certificates” --> "Transcripts/Certificates Earned" for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Christine Kessler, MN, ANP, CNS, BC-ADM, CDTC, FAANP, have disclosed the following relevant financial relationships Speaker's Bureau for Novo Nordisk and Salix Pharmaceuticals.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
